LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 70.08 | 27.76 | 3772 | 6849 | 0.5507 | 0.8554 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 71.78 | 27.76 | 3742 | 6893 | 0.5429 | 0.8522 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 71.78 | 27.76 | 3969 | 6893 | 0.5758 | 0.8659 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 71.78 | 27.76 | 2048 | 6893 | 0.2971 | 0.7170 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 71.78 | 27.76 | 3873 | 6893 | 0.5619 | 0.8602 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 73.48 | 27.76 | 3862 | 6957 | 0.5551 | 0.8576 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 73.48 | 27.76 | 4086 | 6957 | 0.5873 | 0.8708 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 73.48 | 27.76 | 1546 | 6957 | 0.2222 | 0.6560 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 73.48 | 27.76 | 3896 | 6957 | 0.5600 | 0.8596 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 75.19 | 27.76 | 3890 | 7015 | 0.5545 | 0.8576 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 75.19 | 27.76 | 4201 | 7015 | 0.5989 | 0.8756 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 75.19 | 27.76 | 1131 | 7015 | 0.1612 | 0.5912 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 75.19 | 27.76 | 4002 | 7015 | 0.5705 | 0.8642 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 76.89 | 27.76 | 3813 | 7025 | 0.5428 | 0.8526 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 76.89 | 27.76 | 4252 | 7025 | 0.6053 | 0.8781 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 76.89 | 27.76 | 455 | 7025 | 0.0648 | 0.4195 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 76.89 | 27.76 | 4048 | 7025 | 0.5762 | 0.8666 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 78.60 | 27.76 | 3639 | 7045 | 0.5165 | 0.8412 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 78.60 | 27.76 | 4355 | 7045 | 0.6181 | 0.8831 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 78.60 | 27.76 | 381 | 7045 | 0.0541 | 0.3881 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 78.60 | 27.76 | 4066 | 7045 | 0.5771 | 0.8670 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 80.31 | 27.76 | 3471 | 6976 | 0.4976 | 0.8324 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 80.31 | 27.76 | 4451 | 6976 | 0.6380 | 0.8904 | MN20160318_Q01 | D10 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 80.31 | 27.76 | 156 | 6976 | 0.0224 | 0.2417 | MN20160318_Q01 | M06 |
MCF 10A-H2B-mCherry | Dasatinib | 0.1 | 80.31 | 27.76 | 4190 | 6976 | 0.6006 | 0.8761 | MN20160318_Q01 | M06 |